Table: Towa Pharmaceutical -2023/24 group results

TOWA PHARMACEUTICAL

14/05/2024 07:00

May 14 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          227.93          208.86         261.50        122.80   
                                              (+14.7 pct)  (+14.3 pct) 
  Operating       17.65            5.51          18.00          5.20   
                                              (+2.0 pct)   (-25.8 pct) 
  Recurring       24.48            5.14          17.60          5.20   
                                              (-28.1 pct)  (-49.2 pct) 
  Net
  Net             16.17            2.20          11.60          3.10   
                                              (-28.3 pct)  (-55.4 pct) 
  EPS          328.59 yen       44.72 yen     235.67 yen    62.98 yen  
  Ann Div       60.00 yen       60.00 yen      60.00 yen               
  -Q2 Div       30.00 yen       30.00 yen      30.00 yen               
  -Q4 Div       30.00 yen       30.00 yen      30.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T